APA (7th ed.) Citation

John K. Chan, David S. Lakomy, Yassmina McDonald, & Daniel S Kapp. (2020). Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer. Elsevier.

Chicago Style (17th ed.) Citation

John K. Chan, David S. Lakomy, Yassmina McDonald, and Daniel S Kapp. Long-term Durable Responses After Pembrolizumab Immunotherapy for Recurrent, Resistant Endometrial Cancer. Elsevier, 2020.

MLA (9th ed.) Citation

John K. Chan, et al. Long-term Durable Responses After Pembrolizumab Immunotherapy for Recurrent, Resistant Endometrial Cancer. Elsevier, 2020.